Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 December 2021 | Story Martie Miranda and Mosa Moerane | Photo Supplied
The CUADS office promoting accessible learning environments.


Disability inclusive terminology

Twenty years ago, the need was identified to accommodate students with disabilities on the Bloemfontein Campus, and in an attempt to provide an accessible environment and academic life for these students, the Unit for Students with Disabilities was established in February 2001.  The unit started with one staff member, fifteen registered students, and one Braille printer.  Since 2015, the name of the unit has changed to the Centre for Universal Access and Disability Support (CUADS), with offices on all three campuses. There are currently 247 registered students, 13 staff members and three Braille printers, with a pool of ad hoc South African Sign Language interpreters, editors, and amanuensis.


Full integration of students with disabilities 

After 10 years of existence, the unit was ready and committed to look at future possibilities for the full integration of students with disabilities. A lot of work has been done to accommodate students with disabilities across all categories of disability, including study courses, accessibility to buildings, accessibility of learning materials, residences, sporting activities, computer facilities, interpreting services for deaf, hard of hearing, and deafened students, as well as the provision of a specialised exam and test venue for alternative test and exam procedures.

CUADS now forms part of the dynamic student support environment of the Department of Student Affairs, and although the last decade has not been without a lot of growing pains and buy-in from different stakeholders, the centre has aimed to ensure that the University of the Free State (UFS) becomes an accessible higher education institution of choice for students with disabilities. While the primary focus of the support services offered by CUADS is to promote equity for students with disabilities in order to reach academic success, a holistic approach to student participation and success is followed to ensure a humanising experience.  

Universal Access 

CUADS’ involvement with the UFS Integrated Transformation Plan through the Universal Access Work Stream has assisted in integrating disability and universal access matters, which have contributed thus far to the approval of Disability Sport as part of the Integrated Sport Strategy, Disability and Universal Access advocacy as part of the Advocacy, Awareness and Analysis Strategy, including universal access considerations in the UFS Estates Technical Manual for infrastructure, and the Policy on Universal Access and Disability Support for students with disabilities.

Timeline

2001: Establishment of Unit for Students with Disabilities (USD) within Student Counselling and Development
First blind student graduated at the UFS (having been at the UFS without the support service)
2005: First deaf student (Sign Language user) registered, with Sign Language interpreting services provided
2008: Unit became an independent department within Student Affairs
2009: First full-time Sign Language interpreter appointed
2011: Ten-year celebration, embarking on integration of support to students with disabilities
Celebrating a ramp at the front door of the Callie Human Hall as a graduation venue
2012: Alternative exam arrangements integrated with Exam Division
2013: Sign Language interpretation integrated with Interpreting Services
2014: Accessible transport services established between South Campus and Bloemfontein Campus with First Car sponsorship
2015: Name change to Centre for Universal Access and Disability Support (CUADS) and adopting universal access as approach to include students with disabilities
2016: Documenting 40 graduates with disabilities in one year for the first time, which repeated itself in the following years
2017: Became part of the UFS transformation agenda through the UFS Integrated Transformation Plan

Mental health challenges added as a category of students with disabilities supported by CUADS
Formalised orientation and mobility training for students with visual impairments to enable independent movement around our three campuses

2018: Establishment of CUADS offices on South Campus and Qwaqwa Campus, with CUADS coordinators appointed
First Biennial CUADS Formal Function held
2019: Commenced with tactile paving project on Bloemfontein Campus
2020: Disability Sport integrated into ITP Sport Strategy
Disability and Universal Access advocacy integrated with ITP Advocacy, Awareness and Analysis Strategy
2021: Policy on Universal Access and Disability Support for students with disabilities approved by Council
Universal access considerations within the UFS Estates Technical Manual for infrastructure.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept